Oralair

Allergen Extract From Pollen Of Dactylis Glomerata, Anthoxanthum Odoratum, Lolium Perenne, Poa Prate, the active ingredient in Oralair, is a allergen immunotherapy presented as a sublingual tablet for oral use. It is used to treat grass‑pollen induced allergic rhinitis and related rhinoconjunctivitis in adults and children. GNH USA supplies Oralair as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oralair is an allergen immunotherapy that targets grass‑pollen driven allergic airway disease. - Grass pollen allergic rhinitis: reduces nasal congestion, sneezing and itching during the grass season. - Seasonal allergic rhinoconjunctivitis: alleviates both nasal and ocular symptoms caused by grass pollen exposure. - Pediatric grass pollen allergy: provides long‑term symptom control in children as part of a disease‑modifying regimen.

Adverse reactions are generally related to local exposure of the oral mucosa and systemic immune activation.

Common Side Effects: - Oral itching or tingling: mild discomfort in the mouth after dosing. - Throat irritation: transient soreness or scratchy sensation. - Ear pruritus: itching in the ears or around the jaw. - Mild gastrointestinal upset: nausea or abdominal discomfort. - Local swelling of the tongue or lips: transient and self‑limiting.

Serious or Rare Side Effects: - Anaphylaxis: severe, life‑threatening allergic reaction requiring emergency care. - Systemic allergic reaction: widespread urticaria, angioedema or bronchospasm. - Asthma exacerbation: worsening of underlying asthma symptoms. - Laryngeal edema: swelling of the throat that may affect breathing. - Severe gastrointestinal symptoms: persistent vomiting or diarrhea.

Before initiating therapy, patients should be evaluated for contraindications and instructed on proper use. - Contraindication: severe uncontrolled asthma: Oralair should not be started in patients with recent severe asthma attacks. - Medical supervision: first dose must be taken under physician observation to monitor for systemic reactions. - Pregnancy and lactation: use only if clearly needed; discuss risks with a healthcare provider. - Concomitant medications: antihistamines may mask early signs of an allergic reaction; consider timing. - Storage: Store at ambient temperature below 25°C: keep in the original container, protect from moisture and direct sunlight.

Oralair may interact with medications that influence immune response or mask early allergic symptoms.

Major Interactions (Avoid): - Beta‑blockers: may reduce effectiveness of emergency epinephrine in anaphylaxis. - ACE inhibitors: can exacerbate angioedema risk when combined with allergic reactions.

Moderate Interactions (Monitor Closely): - Antihistamines: may conceal early oral itching, delaying detection of a reaction. - Corticosteroids: may alter immune tolerance development, requiring dose adjustment. - Immunosuppressants: could affect the immunomodulatory effect of the allergen extract.